Status:
COMPLETED
Dry Needling in Stroke in Sub-Acute Phase to Improve Upper Limb
Lead Sponsor:
Guadarrama Hospital
Conditions:
Functionality
Spasticity, Muscle
Eligibility:
All Genders
18+ years
Brief Summary
A single-center, observational, prospective, two dynamic cohorts study with before-after design. Group 1: Treatment with 6 sessions using dry needling with DNHS® (Dry Needling for Hypertonicity and Sp...
Detailed Description
Once each patient has signed the informed consent document and it has been verified that the inclusion criteria are met, it will be assigned the same identification number (ID) that is related to its ...
Eligibility Criteria
Inclusion
- They must voluntarily understand and sign the relevant informed consent documents and information sheet, before any evaluation / procedure related to the study is conducted.
- Male or female, ≥ 18 years old at the time of consent.
- Have the diagnosis of hemispheric ischemic or hemorrhagic stroke without excluding other causes (surgical, traumatic, etc ...).
- Show spasticity in the affected upper limb, with an MMAS score of 1-3 in one of the following muscle groups: finger flexors, wrist flexors, elbow flexors, forearm pronators, adductors, or internal rotators of the shoulder.
Exclusion
- Presence of stiffness (score of 4 in MMAS) or hypotonia (MMAS of 0).
- Severe cognitive impairment, severe language problems, severe vision or hearing impairments that prevent compression and active patient collaboration during evaluation tests.
- Have received treatment by injection of Botulinum Toxin A in the 2 months prior to the start of the study.
- Any medical condition that contraindicates dry needling.
- Present some contraindication for the application of dry puncture:
- Pregnancy, insurmountable fear of needles, allergy to metals (nickel), presence of lesions in the puncture area, scars, tattoos...
Key Trial Info
Start Date :
March 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 25 2018
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT03462693
Start Date
March 15 2018
End Date
October 25 2018
Last Update
May 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
J.Nicolas Cuenca Zaldivar
Guadarrama, Madrid, Spain, 28440